Doctor's Choice hands out honors

Share this article:
Merck's Fosamax three-page professional ads and Daiichi Sankyo's one-page Evoxac ad took top honors at the Doctors' Choice Awards.

The Fosamax ad, executed by FCB HealthCare, won the generalist physician category, while the Evoxac ad, by Torre Lazur McCann, won the physician specialty category.

In anti-infectives, an ad for Pfizer's Zyvox by Cline, Davis & Mann took top honors. In cardiovascular, an ad for Merck/Schering-Plough's Vytorin, by Surge Worldwide Healthcare, won first place. In psychiatrics, Forest and KPR won for Campral, and in oncologicals, Genentech and Harrison & Star won for an Avastin ad.

Share this article:

Email Newsletters

More in News

Sanofi expands Gaucher disease portfolio

Sanofi expands Gaucher disease portfolio

The oral medication Cerdelga joins Cerezyme in its Fabry disease arsenal. Sanofi expects the drug will be priced "on par" with Cerezyme, which goes for around $300,000 a year in ...

Amicus seeks to upset Fabry market

Amicus seeks to upset Fabry market

Phase-III tests indicate patients may be able to switch from injectable enzyme-replacement therapies, like Fabrazyme, to the firm's oral drug.

Five things for pharma marketers to know: Wednesday, August 20

Five things for pharma marketers to know: Wednesday, ...

Novartis explores the virtual care space, a court has dismissed a lawsuit against IPAB, Doctors Without Borders calls the Ebola outbreak "a complete disaster" and Pfizer becomes the first pharma ...